首页> 外国专利> METHOD OF MODELLING BIOENGINEERED HEART MATRIX IN EXPERIMENT ON RAT

METHOD OF MODELLING BIOENGINEERED HEART MATRIX IN EXPERIMENT ON RAT

机译:在大鼠实验中模拟生物工程化心脏矩阵的方法

摘要

FIELD: medicine.;SUBSTANCE: method of modelling a bioengineered heart matrix in experiment on a rat includes the introduction of an anticoagulant to the rat, the organ exposure, cleaning it from surrounding adipose tissue, cannulation of the aorta, realisation of decellularisation by perfusion in a bioreactor, as well as control of the quality of the obtained matrix for biocompatibility and viability. The anticoagulant heparin is introduced to the rat intraperitoneally in a dose of 100 U before sampling the heart-lungs organ complex. The aorta is cannuled above the level of the left subclavian artery deviation with the following ligation of the aortic arch branches. Ligation of the orifice of hollow veins is realised, lungs are cut off. Perfusion for decellularisation is realised for 28 hours through the aorta under atmospheric pressure and the rate of the flow of reagents through the organ of 2.4-3.6 ml/min. Perfusion with a phosphate buffer with the addition of 1% of penicillin-streptomycin and deionised water is carried out for 1.5 hours. After that a 4% solution of sodium deoxycholate in a combination with 0.002 M of Na2-EDTA is used for 3.5 hours. The phosphate buffer with the addition of 1% of penicillin-streptomycin is used for 1 hour, porcine pancreatic DNA-ase-I 2000 U/200 ml of the phosphate buffer with calcium and magnesium - for 2.5 hours. Decellularisation is completed with the phosphate buffer with the addition of 1% penicillin-streptomycin with the replacement of the solution every 6 hours. Viability of cells on the obtained matrix is determined by the presence of the differential coloration of live and dead cells, by the ability of the live cells dehydrogenases to recover non-coloured forms of 3-4,5-dimethylthiazol-2yl-2,5-diphenylterarazole to light blue crystalline formazan, soluble in dimethylsulphoxide.;EFFECT: method makes it possible to reduce the time of exposition of perfusion solutions, reduce the probability of bacterial contamination, increase the quality of the obtained matrix in comparison with other methods for the same purpose, estimate the biocompatibility and viability of cells, inoculated on the matrix.;6 dwg
机译:领域:医学;研究对象:在大鼠上对生物工程心脏基质进行建模的方法包括向大鼠中引入抗凝剂,器官暴露,从周围脂肪组织中清除抗凝剂,主动脉插管,通过灌注实现脱细胞在生物反应器中,以及控制获得的基质的生物相容性和生存力的质量。在对心肺器官复合体取样之前,将抗凝肝素以100 U的剂量腹膜内引入大鼠。结扎主动脉弓支后,将主动脉插入左锁骨下动脉偏离水平以上。实现了中空静脉口的结扎,切除了肺。在大气压下通过主动脉进行28小时脱细胞灌注,试剂通过器官的流速为2.4-3.6 ml / min。用磷酸盐缓冲液以及1%的青霉素-链霉素和去离子水灌注1.5小时。之后,将4%的脱氧胆酸钠溶液与0.002M的Na 2 -EDTA组合使用3.5小时。加入1%青霉素-链霉素的磷酸盐缓冲液使用1小时,猪胰腺DNA酶-2000 U / 200 ml含钙和镁的磷酸盐缓冲液使用2.5小时。用磷酸盐缓冲液完成脱细胞作用,加入1%青霉素-链霉素,每6小时更换一次溶液。所获得的基质上细胞的存活力取决于活细胞和死细胞的不同颜色的存在,活细胞脱氢酶回收3-4,5-二甲基噻唑-2yl-2,5的无色形式的能力。 -二苯基四氮杂唑为淡蓝色结晶的甲maz,可溶于二甲亚砜。;效果:与其他方法相比,该方法可以减少灌注溶液的暴露时间,减少细菌污染的可能性,提高获得的基质的质量相同的目的,估计接种在基质上的细胞的生物相容性和生存力。; 6 dwg

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号